106
Mosby items and derived items © 2005, 2002 by Mosby, Inc. 1 CHAPTER 49 Acid-Controlling Agents NDEG 26 A Pharmacology I Eliza Rivera-Mitu, RN, MSN

Mosby items and derived items © 2005, 2002 by Mosby, Inc. 1 CHAPTER 49 Acid-Controlling Agents NDEG 26 A Pharmacology I Eliza Rivera-Mitu, RN, MSN

Embed Size (px)

Citation preview

Page 1: Mosby items and derived items © 2005, 2002 by Mosby, Inc. 1 CHAPTER 49 Acid-Controlling Agents NDEG 26 A Pharmacology I Eliza Rivera-Mitu, RN, MSN

Mosby items and derived items © 2005, 2002 by Mosby, Inc. 1

CHAPTER 49

Acid-Controlling Agents

NDEG 26 APharmacology I

Eliza Rivera-Mitu, RN, MSN

Page 2: Mosby items and derived items © 2005, 2002 by Mosby, Inc. 1 CHAPTER 49 Acid-Controlling Agents NDEG 26 A Pharmacology I Eliza Rivera-Mitu, RN, MSN

Mosby items and derived items © 2005, 2002 by Mosby, Inc. 2

Types of Acid-Controlling Agents

• Antacids

• H2 antagonists

• Proton pump inhibitors

Page 3: Mosby items and derived items © 2005, 2002 by Mosby, Inc. 1 CHAPTER 49 Acid-Controlling Agents NDEG 26 A Pharmacology I Eliza Rivera-Mitu, RN, MSN

Mosby items and derived items © 2005, 2002 by Mosby, Inc. 3

Acid-Related Pathophysiology

The stomach secretes:• Hydrochloric acid (HCl)• Bicarbonate• Pepsinogen• Intrinsic factor• Mucus• Prostaglandins

Page 4: Mosby items and derived items © 2005, 2002 by Mosby, Inc. 1 CHAPTER 49 Acid-Controlling Agents NDEG 26 A Pharmacology I Eliza Rivera-Mitu, RN, MSN

Mosby items and derived items © 2005, 2002 by Mosby, Inc. 4

Glands of the Stomach

• Cardiac

• Pyloric

• Gastric*

* The cells of the gastric gland are the largest in number and of primary importance when discussing acid control

Page 5: Mosby items and derived items © 2005, 2002 by Mosby, Inc. 1 CHAPTER 49 Acid-Controlling Agents NDEG 26 A Pharmacology I Eliza Rivera-Mitu, RN, MSN

Mosby items and derived items © 2005, 2002 by Mosby, Inc. 5

Cells of the Gastric Gland

• Parietal

• Chief

• Mucoid

• Endocrine

• Enterochromaffin

Page 6: Mosby items and derived items © 2005, 2002 by Mosby, Inc. 1 CHAPTER 49 Acid-Controlling Agents NDEG 26 A Pharmacology I Eliza Rivera-Mitu, RN, MSN

Mosby items and derived items © 2005, 2002 by Mosby, Inc. 6

Cells of the Gastric Gland (cont'd)

Parietal cells• Produce and secrete HCl• Primary site of action for many acid-controller

drugs

Page 7: Mosby items and derived items © 2005, 2002 by Mosby, Inc. 1 CHAPTER 49 Acid-Controlling Agents NDEG 26 A Pharmacology I Eliza Rivera-Mitu, RN, MSN

Mosby items and derived items © 2005, 2002 by Mosby, Inc. 7

Cells of the Gastric Gland (cont'd)

Chief cells• Secrete pepsinogen, a proenzyme• Pepsinogen becomes pepsin when activated

by exposure to acid• Pepsin breaks down proteins (proteolytic)

Page 8: Mosby items and derived items © 2005, 2002 by Mosby, Inc. 1 CHAPTER 49 Acid-Controlling Agents NDEG 26 A Pharmacology I Eliza Rivera-Mitu, RN, MSN

Mosby items and derived items © 2005, 2002 by Mosby, Inc. 8

Cells of the Gastric Gland (cont'd)

Mucoid cells• Mucus-secreting cells (surface epithelial

cells)• Provide a protective mucous coat • Protect against self-digestion by HCl

Page 9: Mosby items and derived items © 2005, 2002 by Mosby, Inc. 1 CHAPTER 49 Acid-Controlling Agents NDEG 26 A Pharmacology I Eliza Rivera-Mitu, RN, MSN

Mosby items and derived items © 2005, 2002 by Mosby, Inc. 9

Hydrochloric Acid

• Secreted by the parietal cells when stimulated by food

• Maintains stomach at pH of 1 to 4

• Secretion also stimulated by:– Large fatty meals– Excessive amounts of alcohol– Emotional stress

Page 10: Mosby items and derived items © 2005, 2002 by Mosby, Inc. 1 CHAPTER 49 Acid-Controlling Agents NDEG 26 A Pharmacology I Eliza Rivera-Mitu, RN, MSN

Mosby items and derived items © 2005, 2002 by Mosby, Inc. 10

Acid-Related Diseases

• Caused by imbalance of the three cells of the gastric gland and their secretions

• Most common: hyperacidity

• Lay terms for overproduction of HCl by the parietal cells– indigestion, sour stomach,

heartburn, acid stomach

Page 11: Mosby items and derived items © 2005, 2002 by Mosby, Inc. 1 CHAPTER 49 Acid-Controlling Agents NDEG 26 A Pharmacology I Eliza Rivera-Mitu, RN, MSN

Mosby items and derived items © 2005, 2002 by Mosby, Inc. 11

Acid-Related Diseases (cont'd)

• PUD: peptic ulcer disease• GERD: gastroesophageal reflux disease• Helicobacter pylori (H. pylori)

– Bacterium found in GI tract of 90% of patients with duodenal ulcers, and 70% of those with gastric ulcers

– Antibiotics are used to eradicate H. pylori (tetracycline)

Page 12: Mosby items and derived items © 2005, 2002 by Mosby, Inc. 1 CHAPTER 49 Acid-Controlling Agents NDEG 26 A Pharmacology I Eliza Rivera-Mitu, RN, MSN

Mosby items and derived items © 2005, 2002 by Mosby, Inc. 12

Antacids: Mechanism of Action

Promote gastric mucosal defense mechanisms• Secretion of:

– Mucus: protective barrier against HCl– Bicarbonate: helps buffer acidic properties

of HCl– Prostaglandins: prevent activation of

proton pump

Page 13: Mosby items and derived items © 2005, 2002 by Mosby, Inc. 1 CHAPTER 49 Acid-Controlling Agents NDEG 26 A Pharmacology I Eliza Rivera-Mitu, RN, MSN

Mosby items and derived items © 2005, 2002 by Mosby, Inc. 13

Antacids: Mechanism of Action (cont'd)

• Antacids DO NOT prevent the overproduction of acid

• Antacids DO neutralize the acid once it’s in the stomach

Page 14: Mosby items and derived items © 2005, 2002 by Mosby, Inc. 1 CHAPTER 49 Acid-Controlling Agents NDEG 26 A Pharmacology I Eliza Rivera-Mitu, RN, MSN

Mosby items and derived items © 2005, 2002 by Mosby, Inc. 14

Antacids: Drug Effects

Reduction of pain associated with acid-related disorders• Raising gastric pH from 1.3 to 1.6 neutralizes

50% of the gastric acid• Raising gastric pH 1 point (1.3 to 2.3) neutralizes 90% of the gastric acid• Reducing acidity reduces pain

Page 15: Mosby items and derived items © 2005, 2002 by Mosby, Inc. 1 CHAPTER 49 Acid-Controlling Agents NDEG 26 A Pharmacology I Eliza Rivera-Mitu, RN, MSN

Mosby items and derived items © 2005, 2002 by Mosby, Inc. 15

Antacids

• OTC formulations available as:– Capsules and tablets– Powders– Chewable tablets– Suspensions– Effervescent granules and tablets

Page 16: Mosby items and derived items © 2005, 2002 by Mosby, Inc. 1 CHAPTER 49 Acid-Controlling Agents NDEG 26 A Pharmacology I Eliza Rivera-Mitu, RN, MSN

Mosby items and derived items © 2005, 2002 by Mosby, Inc. 16

Antacids (cont'd)

Used alone or in combination

• Aluminum salts

• Magnesium salts

• Calcium salts

• Sodium bicarbonate

Page 17: Mosby items and derived items © 2005, 2002 by Mosby, Inc. 1 CHAPTER 49 Acid-Controlling Agents NDEG 26 A Pharmacology I Eliza Rivera-Mitu, RN, MSN

Mosby items and derived items © 2005, 2002 by Mosby, Inc. 17

Antacids: Aluminum Salts

• Forms: carbonate, hydroxide• Have constipating effects• Often used with magnesium to counteract

constipation• Examples

– Aluminum carbonate: Basaljel– Hydroxide salt: AlternaGEL– Combination products (aluminum and

magnesium): Gaviscon, Maalox, Mylanta, Di-Gel

Page 18: Mosby items and derived items © 2005, 2002 by Mosby, Inc. 1 CHAPTER 49 Acid-Controlling Agents NDEG 26 A Pharmacology I Eliza Rivera-Mitu, RN, MSN

Mosby items and derived items © 2005, 2002 by Mosby, Inc. 18

Antacids: Magnesium Salts

• Forms: carbonate, hydroxide, oxide, trisilicate• Commonly cause diarrhea; usually used with

other agents to counteract this effect• Dangerous when used with renal failure—the

failing kidney cannot excrete extra magnesium, resulting in accumulation

Page 19: Mosby items and derived items © 2005, 2002 by Mosby, Inc. 1 CHAPTER 49 Acid-Controlling Agents NDEG 26 A Pharmacology I Eliza Rivera-Mitu, RN, MSN

Mosby items and derived items © 2005, 2002 by Mosby, Inc. 19

Antacids: Magnesium Salts (cont'd)

• Examples – Hydroxide salt: magnesium hydroxide

(MOM)– Carbonate salt: Gaviscon (also a

combination product)– Combination products such as Maalox,

Mylanta (aluminum and magnesium)

Page 20: Mosby items and derived items © 2005, 2002 by Mosby, Inc. 1 CHAPTER 49 Acid-Controlling Agents NDEG 26 A Pharmacology I Eliza Rivera-Mitu, RN, MSN

Mosby items and derived items © 2005, 2002 by Mosby, Inc. 20

Antacids: Calcium Salts

Forms: many, but carbonate is most common• May cause constipation• Their use may result in kidney stones• Long duration of acid action may cause

increased gastric acid secretion (hyperacidity rebound)

• Often advertised as an extra source of dietary calcium– Example: Tums (calcium carbonate)

Page 21: Mosby items and derived items © 2005, 2002 by Mosby, Inc. 1 CHAPTER 49 Acid-Controlling Agents NDEG 26 A Pharmacology I Eliza Rivera-Mitu, RN, MSN

Mosby items and derived items © 2005, 2002 by Mosby, Inc. 21

Antacids: Sodium Bicarbonate

• Highly soluble• Buffers the acidic properties of HCl• Quick onset, but short duration• May cause metabolic (systemic)

alkalosis when used excessively• Sodium content may cause problems in

patients with HF, hypertension, or renal insufficiency

Page 22: Mosby items and derived items © 2005, 2002 by Mosby, Inc. 1 CHAPTER 49 Acid-Controlling Agents NDEG 26 A Pharmacology I Eliza Rivera-Mitu, RN, MSN

Mosby items and derived items © 2005, 2002 by Mosby, Inc. 22

Antacids and Antiflatulents

• Antiflatulents: used to relieve the painful symptoms associated with gas

• Several agents are used to bind or alter intestinal gas and are often added to antacid combination products

Page 23: Mosby items and derived items © 2005, 2002 by Mosby, Inc. 1 CHAPTER 49 Acid-Controlling Agents NDEG 26 A Pharmacology I Eliza Rivera-Mitu, RN, MSN

Mosby items and derived items © 2005, 2002 by Mosby, Inc. 23

Antacids and Antiflatulents (cont'd)

OTC antiflatulents• Activated charcoal• Simethicone

– Alters elasticity of mucus-coated bubbles, causing them to break

– Used often, but there are limited data to support effectiveness

Page 24: Mosby items and derived items © 2005, 2002 by Mosby, Inc. 1 CHAPTER 49 Acid-Controlling Agents NDEG 26 A Pharmacology I Eliza Rivera-Mitu, RN, MSN

Mosby items and derived items © 2005, 2002 by Mosby, Inc. 24

Antacids: Side Effects

Minimal, and depend on the compound used• Aluminum and calcium

– Constipation

• Magnesium– Diarrhea

• Calcium carbonate– Produces gas and belching; often combined

with simethicone

Page 25: Mosby items and derived items © 2005, 2002 by Mosby, Inc. 1 CHAPTER 49 Acid-Controlling Agents NDEG 26 A Pharmacology I Eliza Rivera-Mitu, RN, MSN

Mosby items and derived items © 2005, 2002 by Mosby, Inc. 25

Antacids: Drug Interactions

• Adsorption of other drugs to antacids– Reduces the ability of the other drug to be

absorbed into the body

• Chelation– Chemical binding, or inactivation, of

another drug– Produces insoluble complexes– Result: reduced drug absorption

Page 26: Mosby items and derived items © 2005, 2002 by Mosby, Inc. 1 CHAPTER 49 Acid-Controlling Agents NDEG 26 A Pharmacology I Eliza Rivera-Mitu, RN, MSN

Mosby items and derived items © 2005, 2002 by Mosby, Inc. 26

Antacids: Drug Interactions (cont'd)

Increased stomach pH• Increased absorption of basic drugs• Decreased absorption of acidic drugs

Increased urinary pH• Increased excretion of acidic drugs• Decreased excretion of basic drugs

Page 27: Mosby items and derived items © 2005, 2002 by Mosby, Inc. 1 CHAPTER 49 Acid-Controlling Agents NDEG 26 A Pharmacology I Eliza Rivera-Mitu, RN, MSN

Mosby items and derived items © 2005, 2002 by Mosby, Inc. 27

Antacids: Nursing Implications

• Assess for allergies and preexisting conditions that may restrict the use of antacids, such as:– Fluid imbalances – Renal disease – HF– Pregnancy – GI obstruction

• Patients with HF or hypertension should use low-sodium antacids such as Riopan, Maalox, or Mylanta II

Page 28: Mosby items and derived items © 2005, 2002 by Mosby, Inc. 1 CHAPTER 49 Acid-Controlling Agents NDEG 26 A Pharmacology I Eliza Rivera-Mitu, RN, MSN

Mosby items and derived items © 2005, 2002 by Mosby, Inc. 28

Antacids: Nursing Implications

• Use with caution with other medications due to the many drug interactions

• Most medications should be given 1 to 2 hours after giving an antacid

• Antacids may cause premature dissolving of enteric-coated medications, resulting in stomach upset

Page 29: Mosby items and derived items © 2005, 2002 by Mosby, Inc. 1 CHAPTER 49 Acid-Controlling Agents NDEG 26 A Pharmacology I Eliza Rivera-Mitu, RN, MSN

Mosby items and derived items © 2005, 2002 by Mosby, Inc. 29

Antacids: Nursing Implications

• Be sure that chewable tablets are chewed thoroughly, and liquid forms are shaken well before giving

• Administer with at least 8 ounces of water to enhance absorption (except for the “rapid dissolve” forms)

• Caffeine, alcohol, harsh spices, and black pepper may aggravate the underlying GI condition

Page 30: Mosby items and derived items © 2005, 2002 by Mosby, Inc. 1 CHAPTER 49 Acid-Controlling Agents NDEG 26 A Pharmacology I Eliza Rivera-Mitu, RN, MSN

Mosby items and derived items © 2005, 2002 by Mosby, Inc. 30

Antacids: Nursing Implications

• Monitor for side effects– Nausea, vomiting, abdominal pain,

diarrhea– With calcium-containing products:

constipation, acid rebound

• Monitor for therapeutic response– Notify heath care provider if symptoms are

not relieved

Page 31: Mosby items and derived items © 2005, 2002 by Mosby, Inc. 1 CHAPTER 49 Acid-Controlling Agents NDEG 26 A Pharmacology I Eliza Rivera-Mitu, RN, MSN

Mosby items and derived items © 2005, 2002 by Mosby, Inc. 31

Histamine Type 2 (H2) Antagonists

• Reduce acid secretion

• All available OTC in lower dosage forms

• Most popular drugs for treatment of acid-related disorders– cimetidine (Tagamet) – nizatidine– famotidine (Pepcid)– ranitidine (Zantac)

Page 32: Mosby items and derived items © 2005, 2002 by Mosby, Inc. 1 CHAPTER 49 Acid-Controlling Agents NDEG 26 A Pharmacology I Eliza Rivera-Mitu, RN, MSN

Mosby items and derived items © 2005, 2002 by Mosby, Inc. 32

H2 Antagonists: Mechanism of Action

• Block histamine (H2) at the receptors of acid-producing parietal cells

• Production of hydrogen ions is reduced, resulting in decreased production of HCl

Page 33: Mosby items and derived items © 2005, 2002 by Mosby, Inc. 1 CHAPTER 49 Acid-Controlling Agents NDEG 26 A Pharmacology I Eliza Rivera-Mitu, RN, MSN

Mosby items and derived items © 2005, 2002 by Mosby, Inc. 33

H2 Antagonists: Drug Effect

Suppressed acid secretion in the stomach

Page 34: Mosby items and derived items © 2005, 2002 by Mosby, Inc. 1 CHAPTER 49 Acid-Controlling Agents NDEG 26 A Pharmacology I Eliza Rivera-Mitu, RN, MSN

Mosby items and derived items © 2005, 2002 by Mosby, Inc. 34

H2 Antagonists: Indications

• GERD

• PUD

• Erosive esophagitis

• Adjunct therapy in control of upper GI bleeding

• Pathologic gastric hypersecretory conditions

Page 35: Mosby items and derived items © 2005, 2002 by Mosby, Inc. 1 CHAPTER 49 Acid-Controlling Agents NDEG 26 A Pharmacology I Eliza Rivera-Mitu, RN, MSN

Mosby items and derived items © 2005, 2002 by Mosby, Inc. 35

H2 Antagonists: Side Effects

• Overall, less than 3% incidence of side effects

• Cimetidine may induce impotence and gynecomastia

• May see:– Headaches, lethargy, confusion, diarrhea,

urticaria, sweating, flushing, other effects

Page 36: Mosby items and derived items © 2005, 2002 by Mosby, Inc. 1 CHAPTER 49 Acid-Controlling Agents NDEG 26 A Pharmacology I Eliza Rivera-Mitu, RN, MSN

Mosby items and derived items © 2005, 2002 by Mosby, Inc. 36

H2 Antagonists: Drug Interactions

• cimetidine– Binds with P-450 microsomal oxidase

system in the liver, resulting in inhibited oxidation of many drugs and increased drug levels

– All H2 antagonists may inhibit the absorption of drugs that require an acidic GI environment for absorption (Example: Ketoconazole)

Page 37: Mosby items and derived items © 2005, 2002 by Mosby, Inc. 1 CHAPTER 49 Acid-Controlling Agents NDEG 26 A Pharmacology I Eliza Rivera-Mitu, RN, MSN

Mosby items and derived items © 2005, 2002 by Mosby, Inc. 37

H2 Antagonists: Drug Interactions (cont'd)

SMOKING has been shown to decrease the effectiveness of H2 blockers

Page 38: Mosby items and derived items © 2005, 2002 by Mosby, Inc. 1 CHAPTER 49 Acid-Controlling Agents NDEG 26 A Pharmacology I Eliza Rivera-Mitu, RN, MSN

Mosby items and derived items © 2005, 2002 by Mosby, Inc. 38

H2 Antagonists: Nursing Implications

• Assess for allergies and impaired renal or liver function

• Use with caution in patients who are confused, disoriented, or elderly

• Take 1 hour before or after antacids

• For intravenous doses, follow administration guidelines

Page 39: Mosby items and derived items © 2005, 2002 by Mosby, Inc. 1 CHAPTER 49 Acid-Controlling Agents NDEG 26 A Pharmacology I Eliza Rivera-Mitu, RN, MSN

Mosby items and derived items © 2005, 2002 by Mosby, Inc. 39

Proton Pump

• The parietal cells release positive hydrogen ions (protons) during HCl production

• This process is called the “proton pump”

• H2 blockers and antihistamines do not stop the action of this pump

Page 40: Mosby items and derived items © 2005, 2002 by Mosby, Inc. 1 CHAPTER 49 Acid-Controlling Agents NDEG 26 A Pharmacology I Eliza Rivera-Mitu, RN, MSN

Mosby items and derived items © 2005, 2002 by Mosby, Inc. 40

Proton Pump Inhibitors: Mechanism of Action

• Irreversibly bind to H+/K+ ATPase enzyme• This bond prevents the movement of

hydrogen ions from the parietal cell into the stomach

• Result: achlorhydria—ALL gastric acid secretion is blocked– In order to return to normal acid secretion, the

parietal cell must synthesize new H+/K+ ATPase

Page 41: Mosby items and derived items © 2005, 2002 by Mosby, Inc. 1 CHAPTER 49 Acid-Controlling Agents NDEG 26 A Pharmacology I Eliza Rivera-Mitu, RN, MSN

Mosby items and derived items © 2005, 2002 by Mosby, Inc. 41

Proton Pump Inhibitors: Drug Effect

• Total inhibition of gastric acid secretion– lansoprazole (Prevacid)– omeprazole (Prilosec)*– rabeprazole (Aciphex)– pantoprazole (Protonix)– esomeprazole (Nexium)

*The first in this new class of drugs

Page 42: Mosby items and derived items © 2005, 2002 by Mosby, Inc. 1 CHAPTER 49 Acid-Controlling Agents NDEG 26 A Pharmacology I Eliza Rivera-Mitu, RN, MSN

Mosby items and derived items © 2005, 2002 by Mosby, Inc. 42

Proton Pump Inhibitors: Indications

• GERD maintenance therapy• Erosive esophagitis• Short-term treatment of active duodenal

and benign gastric ulcers• Zollinger-Ellison syndrome• Treatment of H. pylori–induced ulcers;

usually combined with antibiotic such as clarithromycin (Biaxin)

Page 43: Mosby items and derived items © 2005, 2002 by Mosby, Inc. 1 CHAPTER 49 Acid-Controlling Agents NDEG 26 A Pharmacology I Eliza Rivera-Mitu, RN, MSN

Mosby items and derived items © 2005, 2002 by Mosby, Inc. 43

Proton Pump Inhibitors: Side Effects

• Safe for short-term therapy

• Incidence low and uncommon

Page 44: Mosby items and derived items © 2005, 2002 by Mosby, Inc. 1 CHAPTER 49 Acid-Controlling Agents NDEG 26 A Pharmacology I Eliza Rivera-Mitu, RN, MSN

Mosby items and derived items © 2005, 2002 by Mosby, Inc. 44

Proton Pump Inhibitors: Nursing Implications

• Assess for allergies and history of liver disease

• pantoprazole is the only proton pump inhibitor available for parenteral administration, and can be used for patients who are unable to take oral medications

• May increase serum levels of diazepam, phenytoin, and cause increased chance for bleeding with warfarin

Page 45: Mosby items and derived items © 2005, 2002 by Mosby, Inc. 1 CHAPTER 49 Acid-Controlling Agents NDEG 26 A Pharmacology I Eliza Rivera-Mitu, RN, MSN

Mosby items and derived items © 2005, 2002 by Mosby, Inc. 45

Proton Pump Inhibitors: Nursing Implications

Instruct the patient taking omeprazole:• It should be taken before meals• The capsule should be swallowed whole, not

crushed, opened, or chewed• It may be given with antacids• Emphasize that the treatment will be short

term

Page 46: Mosby items and derived items © 2005, 2002 by Mosby, Inc. 1 CHAPTER 49 Acid-Controlling Agents NDEG 26 A Pharmacology I Eliza Rivera-Mitu, RN, MSN

Mosby items and derived items © 2005, 2002 by Mosby, Inc. 46

Other Drugs

• sucralfate (Carafate)

• misoprostol (Cytotec)

Page 47: Mosby items and derived items © 2005, 2002 by Mosby, Inc. 1 CHAPTER 49 Acid-Controlling Agents NDEG 26 A Pharmacology I Eliza Rivera-Mitu, RN, MSN

Mosby items and derived items © 2005, 2002 by Mosby, Inc. 47

sucralfate (Carafate)

• Cytoprotective agent• Used for stress ulcers, erosions, PUD• Attracted to and binds to the base of ulcers

and erosions, forming a protective barrier over these areas

• Protects these areas from pepsin, which normally breaks down proteins (making ulcers worse)

Page 48: Mosby items and derived items © 2005, 2002 by Mosby, Inc. 1 CHAPTER 49 Acid-Controlling Agents NDEG 26 A Pharmacology I Eliza Rivera-Mitu, RN, MSN

Mosby items and derived items © 2005, 2002 by Mosby, Inc. 48

sucralfate (Carafate) (cont'd)

• Little absorption from the gut• May cause constipation, nausea, and dry

mouth• May impair absorption of other drugs,

especially tetracycline• Binds with phosphate; may be used in chronic

renal failure to reduce phosphate levels• Do not administer with other medications

Page 49: Mosby items and derived items © 2005, 2002 by Mosby, Inc. 1 CHAPTER 49 Acid-Controlling Agents NDEG 26 A Pharmacology I Eliza Rivera-Mitu, RN, MSN

Mosby items and derived items © 2005, 2002 by Mosby, Inc. 49

misoprostol (Cytotec)

• Synthetic prostaglandin analog

• Prostaglandins have cytoprotective activity– Protect gastric mucosa from injury by

enhancing local production of mucus or bicarbonate

– Promote local cell regeneration– Help to maintain mucosal blood flow

Page 50: Mosby items and derived items © 2005, 2002 by Mosby, Inc. 1 CHAPTER 49 Acid-Controlling Agents NDEG 26 A Pharmacology I Eliza Rivera-Mitu, RN, MSN

Mosby items and derived items © 2005, 2002 by Mosby, Inc. 50

misoprostol (Cytotec) (cont'd)

• Used for prevention of NSAID-induced gastric ulcers

• Doses that are therapeutic enough to treat duodenal ulcers often produce abdominal cramps, diarrhea

Page 51: Mosby items and derived items © 2005, 2002 by Mosby, Inc. 1 CHAPTER 49 Acid-Controlling Agents NDEG 26 A Pharmacology I Eliza Rivera-Mitu, RN, MSN

Mosby items and derived items © 2005, 2002 by Mosby, Inc. 51

CHAPTER 50

Antidiarrheals and Laxatives

Page 52: Mosby items and derived items © 2005, 2002 by Mosby, Inc. 1 CHAPTER 49 Acid-Controlling Agents NDEG 26 A Pharmacology I Eliza Rivera-Mitu, RN, MSN

Mosby items and derived items © 2005, 2002 by Mosby, Inc. 52

Diarrhea

• Abnormal frequent passage of loose stools

or

• Abnormal passage of stools with increased frequency, fluidity, and weight, or with increased stool water excretion

Page 53: Mosby items and derived items © 2005, 2002 by Mosby, Inc. 1 CHAPTER 49 Acid-Controlling Agents NDEG 26 A Pharmacology I Eliza Rivera-Mitu, RN, MSN

Mosby items and derived items © 2005, 2002 by Mosby, Inc. 53

Diarrhea (cont'd)

Acute diarrhea

• Sudden onset in a previously healthy person

• Lasts from 3 days to 2 weeks

• Self-limiting

• Resolves without sequelae

Page 54: Mosby items and derived items © 2005, 2002 by Mosby, Inc. 1 CHAPTER 49 Acid-Controlling Agents NDEG 26 A Pharmacology I Eliza Rivera-Mitu, RN, MSN

Mosby items and derived items © 2005, 2002 by Mosby, Inc. 54

Diarrhea (cont'd)

Chronic diarrhea

• Lasts for more than 3 weeks

• Associated with recurring passage of diarrheal stools, fever, loss of appetite, nausea, vomiting, weight loss, and chronic weakness

Page 55: Mosby items and derived items © 2005, 2002 by Mosby, Inc. 1 CHAPTER 49 Acid-Controlling Agents NDEG 26 A Pharmacology I Eliza Rivera-Mitu, RN, MSN

Mosby items and derived items © 2005, 2002 by Mosby, Inc. 55

Causes of Diarrhea

Acute Diarrhea

Bacterial

Viral

Drug induced

Nutritional

Protozoal

Chronic Diarrhea

Tumors

Diabetes

Addison’s disease

Hyperthyroidism

Irritable bowel syndrome

Page 56: Mosby items and derived items © 2005, 2002 by Mosby, Inc. 1 CHAPTER 49 Acid-Controlling Agents NDEG 26 A Pharmacology I Eliza Rivera-Mitu, RN, MSN

Mosby items and derived items © 2005, 2002 by Mosby, Inc. 56

Antidiarrheals: Mechanism of Action

Adsorbents• Coat the walls of the GI tract• Bind to the causative bacteria or toxin,

which is then eliminated through the stool

• Examples: bismuth subsalicylate (Pepto-Bismol), kaolin-pectin, activated charcoal, attapulgite (Kaopectate)

Page 57: Mosby items and derived items © 2005, 2002 by Mosby, Inc. 1 CHAPTER 49 Acid-Controlling Agents NDEG 26 A Pharmacology I Eliza Rivera-Mitu, RN, MSN

Mosby items and derived items © 2005, 2002 by Mosby, Inc. 57

Antidiarrheals: Mechanism of Action (cont'd)

Anticholinergics• Decrease intestinal muscle tone and

peristalsis of GI tract• Result: slowing the movement of fecal

matter through the GI tract• Examples: belladonna alkaloids

(Donnatal), atropine (Lomotil), hyoscyamine

Page 58: Mosby items and derived items © 2005, 2002 by Mosby, Inc. 1 CHAPTER 49 Acid-Controlling Agents NDEG 26 A Pharmacology I Eliza Rivera-Mitu, RN, MSN

Mosby items and derived items © 2005, 2002 by Mosby, Inc. 58

Antidiarrheals: Mechanism of Action (cont'd)

Intestinal flora modifiers• Bacterial cultures of Lactobacillus organisms

work by:– Supplying missing bacteria to the GI tract– Suppressing the growth of diarrhea-

causing bacteria• Example: L. acidophilus (Lactinex)

Page 59: Mosby items and derived items © 2005, 2002 by Mosby, Inc. 1 CHAPTER 49 Acid-Controlling Agents NDEG 26 A Pharmacology I Eliza Rivera-Mitu, RN, MSN

Mosby items and derived items © 2005, 2002 by Mosby, Inc. 59

Antidiarrheals: Mechanism of Action (cont'd)

Opiates• Decrease bowel motility and relieve rectal

spasms• Decrease transit time through the bowel,

allowing more time for water and electrolytes to be absorbed

• Examples: paregoric, opium tincture, codeine, loperamide (Imodium), diphenoxylate

• Although an opiate, dependence has not been reported

Page 60: Mosby items and derived items © 2005, 2002 by Mosby, Inc. 1 CHAPTER 49 Acid-Controlling Agents NDEG 26 A Pharmacology I Eliza Rivera-Mitu, RN, MSN

Mosby items and derived items © 2005, 2002 by Mosby, Inc. 60

Antidiarrheal Agents: Side Effects

Adsorbents

• Increased bleeding time

• Constipation, dark stools

• Confusion, twitching

• Hearing loss, tinnitus, metallic taste, blue gums

Page 61: Mosby items and derived items © 2005, 2002 by Mosby, Inc. 1 CHAPTER 49 Acid-Controlling Agents NDEG 26 A Pharmacology I Eliza Rivera-Mitu, RN, MSN

Mosby items and derived items © 2005, 2002 by Mosby, Inc. 61

Antidiarrheal Agents: Side Effects (cont'd)

Anticholinergics• Urinary retention, hesitancy, impotence• Headache, dizziness, confusion, anxiety,

drowsiness• Dry skin, rash, flushing• Blurred vision, photophobia, increased

intraocular pressure• Hypotension, hypertension, bradycardia,

tachycardia

Page 62: Mosby items and derived items © 2005, 2002 by Mosby, Inc. 1 CHAPTER 49 Acid-Controlling Agents NDEG 26 A Pharmacology I Eliza Rivera-Mitu, RN, MSN

Mosby items and derived items © 2005, 2002 by Mosby, Inc. 62

Antidiarrheal Agents: Side Effects (cont'd)

Opiates• Drowsiness, sedation, dizziness, lethargy• Nausea, vomiting, anorexia, constipation• Respiratory depression• Bradycardia, palpitations, hypotension• Urinary retention• Flushing, rash, urticaria

Page 63: Mosby items and derived items © 2005, 2002 by Mosby, Inc. 1 CHAPTER 49 Acid-Controlling Agents NDEG 26 A Pharmacology I Eliza Rivera-Mitu, RN, MSN

Mosby items and derived items © 2005, 2002 by Mosby, Inc. 63

Antidiarrheal Agents: Interactions

• Adsorbents decrease the absorption of many agents, including digoxin (Lanoxin), clindamycin, quinidine, and hypoglycemic agents

• Adsorbents cause increased bleeding time when given with anticoagulants

• Antacids can decrease effects of anticholinergic antidiarrheal agents

Page 64: Mosby items and derived items © 2005, 2002 by Mosby, Inc. 1 CHAPTER 49 Acid-Controlling Agents NDEG 26 A Pharmacology I Eliza Rivera-Mitu, RN, MSN

Mosby items and derived items © 2005, 2002 by Mosby, Inc. 64

Antidiarrheal Agents: Nursing Implications

• Obtain thorough history of bowel patterns, general state of health, and recent history of illness or dietary changes, and assess for allergies

• DO NOT give bismuth subsalicylate to children younger than age 16 or teenagers with chickenpox because of the risk of Reye’s syndrome

Page 65: Mosby items and derived items © 2005, 2002 by Mosby, Inc. 1 CHAPTER 49 Acid-Controlling Agents NDEG 26 A Pharmacology I Eliza Rivera-Mitu, RN, MSN

Mosby items and derived items © 2005, 2002 by Mosby, Inc. 65

Antidiarrheal Agents: Nursing Implications

• Use adsorbents carefully in geriatric patients or those with decreased bleeding time, clotting disorders, recent bowel surgery, confusion

• Anticholinergics should not be administered to patients with a history of glaucoma, BPH, urinary retention, recent bladder surgery, cardiac problems, myasthenia gravis

Page 66: Mosby items and derived items © 2005, 2002 by Mosby, Inc. 1 CHAPTER 49 Acid-Controlling Agents NDEG 26 A Pharmacology I Eliza Rivera-Mitu, RN, MSN

Mosby items and derived items © 2005, 2002 by Mosby, Inc. 66

Antidiarrheal Agents: Nursing Implications

• Teach patients to take medications exactly as prescribed and to be aware of their fluid intake and dietary changes

• Assess fluid volume status, I&O, and mucous membranes before, during, and after initiation of treatment

Page 67: Mosby items and derived items © 2005, 2002 by Mosby, Inc. 1 CHAPTER 49 Acid-Controlling Agents NDEG 26 A Pharmacology I Eliza Rivera-Mitu, RN, MSN

Mosby items and derived items © 2005, 2002 by Mosby, Inc. 67

Antidiarrheal Agents: Nursing Implications

• Teach patients to notify their physician immediately if symptoms persist

• Monitor for therapeutic effect

Page 68: Mosby items and derived items © 2005, 2002 by Mosby, Inc. 1 CHAPTER 49 Acid-Controlling Agents NDEG 26 A Pharmacology I Eliza Rivera-Mitu, RN, MSN

Mosby items and derived items © 2005, 2002 by Mosby, Inc. 68

Laxatives

Page 69: Mosby items and derived items © 2005, 2002 by Mosby, Inc. 1 CHAPTER 49 Acid-Controlling Agents NDEG 26 A Pharmacology I Eliza Rivera-Mitu, RN, MSN

Mosby items and derived items © 2005, 2002 by Mosby, Inc. 69

Constipation

• Abnormally infrequent and difficult passage of feces through the lower GI tract

• Symptom, not a disease• Disorder of movement through the colon

and/or rectum• Can be caused by a variety of diseases

or drugs

Page 70: Mosby items and derived items © 2005, 2002 by Mosby, Inc. 1 CHAPTER 49 Acid-Controlling Agents NDEG 26 A Pharmacology I Eliza Rivera-Mitu, RN, MSN

Mosby items and derived items © 2005, 2002 by Mosby, Inc. 70

Laxatives: Mechanism of Action

• Bulk forming

• Emollient

• Hyperosmotic

• Saline

• Stimulant

Page 71: Mosby items and derived items © 2005, 2002 by Mosby, Inc. 1 CHAPTER 49 Acid-Controlling Agents NDEG 26 A Pharmacology I Eliza Rivera-Mitu, RN, MSN

Mosby items and derived items © 2005, 2002 by Mosby, Inc. 71

Laxatives: Mechanism of Action (cont'd)

Bulk forming• High fiber• Absorbs water to increase bulk• Distends bowel to initiate reflex bowel activity• Examples:

– psyllium (Metamucil)– methylcellulose (Citrucel)– polycarbophil

Page 72: Mosby items and derived items © 2005, 2002 by Mosby, Inc. 1 CHAPTER 49 Acid-Controlling Agents NDEG 26 A Pharmacology I Eliza Rivera-Mitu, RN, MSN

Mosby items and derived items © 2005, 2002 by Mosby, Inc. 72

Laxatives: Mechanism of Action (cont'd)

Emollient• Stool softeners and lubricants• Promote more water and fat in the stools• Lubricate the fecal material and intestinal

walls• Examples:

– Stool softeners: docusate salts (Colace, Surfak)– Lubricants: mineral oil

Page 73: Mosby items and derived items © 2005, 2002 by Mosby, Inc. 1 CHAPTER 49 Acid-Controlling Agents NDEG 26 A Pharmacology I Eliza Rivera-Mitu, RN, MSN

Mosby items and derived items © 2005, 2002 by Mosby, Inc. 73

Laxatives: Mechanism of Action (cont'd)

Hyperosmotic• Increase fecal water content• Result: bowel distention, increased

peristalsis, and evacuation• Examples:

– polyethylene glycol (GoLYTELY) – Used before diagnostic or surgical bowel procedures

– sorbitol– glycerin– lactulose (Chronulac)

Page 74: Mosby items and derived items © 2005, 2002 by Mosby, Inc. 1 CHAPTER 49 Acid-Controlling Agents NDEG 26 A Pharmacology I Eliza Rivera-Mitu, RN, MSN

Mosby items and derived items © 2005, 2002 by Mosby, Inc. 74

Laxatives: Mechanism of Action (cont'd)

Saline

• Increase osmotic pressure within the intestinal tract, causing more water to enter the intestines

• Result: bowel distention, increased peristalsis, and evacuation

Page 75: Mosby items and derived items © 2005, 2002 by Mosby, Inc. 1 CHAPTER 49 Acid-Controlling Agents NDEG 26 A Pharmacology I Eliza Rivera-Mitu, RN, MSN

Mosby items and derived items © 2005, 2002 by Mosby, Inc. 75

Laxatives: Mechanism of Action (cont'd)

• Saline laxative examples:– magnesium sulfate (Epsom salts)– magnesium hydroxide (MOM)– magnesium citrate– sodium phosphate (Fleet Phospho-Soda,

Fleet enema)

Page 76: Mosby items and derived items © 2005, 2002 by Mosby, Inc. 1 CHAPTER 49 Acid-Controlling Agents NDEG 26 A Pharmacology I Eliza Rivera-Mitu, RN, MSN

Mosby items and derived items © 2005, 2002 by Mosby, Inc. 76

Laxatives: Mechanism of Action (cont'd)

Stimulant• Increases peristalsis via intestinal nerve

stimulation• Examples:

– castor oil– senna– cascara

– bisacodyl

Page 77: Mosby items and derived items © 2005, 2002 by Mosby, Inc. 1 CHAPTER 49 Acid-Controlling Agents NDEG 26 A Pharmacology I Eliza Rivera-Mitu, RN, MSN

Mosby items and derived items © 2005, 2002 by Mosby, Inc. 77

Laxatives: Indications

Laxative GroupBulk forming

Emollient

UseAcute and chronic

constipation

Irritable bowel syndrome

Diverticulosis

Acute and chronic constipation

Softening of fecal impaction; facilitation of BMs in anorectal conditions

Page 78: Mosby items and derived items © 2005, 2002 by Mosby, Inc. 1 CHAPTER 49 Acid-Controlling Agents NDEG 26 A Pharmacology I Eliza Rivera-Mitu, RN, MSN

Mosby items and derived items © 2005, 2002 by Mosby, Inc. 78

Laxatives: Indications (cont'd)

Laxative GroupHyperosmotic

Saline

UseChronic constipation

Diagnostic and surgical preps

Constipation

Diagnostic and surgical preps

Removal of helminths and parasites

Page 79: Mosby items and derived items © 2005, 2002 by Mosby, Inc. 1 CHAPTER 49 Acid-Controlling Agents NDEG 26 A Pharmacology I Eliza Rivera-Mitu, RN, MSN

Mosby items and derived items © 2005, 2002 by Mosby, Inc. 79

Laxatives: Indications (cont'd)

Laxative GroupStimulant

UseAcute constipation

Diagnostic and surgical bowel preps

Page 80: Mosby items and derived items © 2005, 2002 by Mosby, Inc. 1 CHAPTER 49 Acid-Controlling Agents NDEG 26 A Pharmacology I Eliza Rivera-Mitu, RN, MSN

Mosby items and derived items © 2005, 2002 by Mosby, Inc. 80

Laxatives: Side Effects

• Bulk forming– Impaction– Fluid overload

• Emollient– Skin rashes– Decreased absorption of fat-soluble vitamins A, D, E, &

K

• Hyperosmotic– Abdominal bloating– Rectal irritation

Page 81: Mosby items and derived items © 2005, 2002 by Mosby, Inc. 1 CHAPTER 49 Acid-Controlling Agents NDEG 26 A Pharmacology I Eliza Rivera-Mitu, RN, MSN

Mosby items and derived items © 2005, 2002 by Mosby, Inc. 81

Laxatives: Side Effects (cont'd)

• Saline– Magnesium toxicity (with renal insufficiency)– Cramping– Diarrhea– Increased thirst

• Stimulant– Nutrient malabsorption– Skin rashes– Gastric irritation– Rectal irritation– Can cause dependence if overused

Page 82: Mosby items and derived items © 2005, 2002 by Mosby, Inc. 1 CHAPTER 49 Acid-Controlling Agents NDEG 26 A Pharmacology I Eliza Rivera-Mitu, RN, MSN

Mosby items and derived items © 2005, 2002 by Mosby, Inc. 82

Laxatives: Side Effects (cont'd)

All laxatives can cause electrolyte imbalances!

Page 83: Mosby items and derived items © 2005, 2002 by Mosby, Inc. 1 CHAPTER 49 Acid-Controlling Agents NDEG 26 A Pharmacology I Eliza Rivera-Mitu, RN, MSN

Mosby items and derived items © 2005, 2002 by Mosby, Inc. 83

Laxatives: Nursing Implications

• Obtain a thorough history of presenting symptoms, elimination patterns, and allergies

• Assess fluid and electrolytes before initiating therapy

• Patients should not take a laxative or cathartic if they are experiencing nausea, vomiting, and/or abdominal pain

Page 84: Mosby items and derived items © 2005, 2002 by Mosby, Inc. 1 CHAPTER 49 Acid-Controlling Agents NDEG 26 A Pharmacology I Eliza Rivera-Mitu, RN, MSN

Mosby items and derived items © 2005, 2002 by Mosby, Inc. 84

Laxatives: Nursing Implications

• A healthy, high-fiber diet and increased fluid intake should be encouraged as an alternative to laxative use

• Long-term use of laxatives often results in decreased bowel tone and may lead to dependency

• All laxative tablets should be swallowed whole, not crushed or chewed, especially if enteric coated

Page 85: Mosby items and derived items © 2005, 2002 by Mosby, Inc. 1 CHAPTER 49 Acid-Controlling Agents NDEG 26 A Pharmacology I Eliza Rivera-Mitu, RN, MSN

Mosby items and derived items © 2005, 2002 by Mosby, Inc. 85

Laxatives: Nursing Implications

• Patients should take all laxative tablets with 6 to 8 ounces of water

• Patients should take bulk-forming laxatives as directed by the manufacturer with at least 240 mL (8 ounces) of water

Page 86: Mosby items and derived items © 2005, 2002 by Mosby, Inc. 1 CHAPTER 49 Acid-Controlling Agents NDEG 26 A Pharmacology I Eliza Rivera-Mitu, RN, MSN

Mosby items and derived items © 2005, 2002 by Mosby, Inc. 86

Laxatives: Nursing Implications

• Bisacodyl and cascara sagrada should be given with water due to interactions with milk, antacids, and H2 blockers

• Patients should contact their physician if they experience severe abdominal pain, muscle weakness, cramps, and/or dizziness, which may indicate possible fluid or electrolyte loss

Page 87: Mosby items and derived items © 2005, 2002 by Mosby, Inc. 1 CHAPTER 49 Acid-Controlling Agents NDEG 26 A Pharmacology I Eliza Rivera-Mitu, RN, MSN

Mosby items and derived items © 2005, 2002 by Mosby, Inc. 87

Laxatives: Nursing Implications

• Monitor for therapeutic effect

Page 88: Mosby items and derived items © 2005, 2002 by Mosby, Inc. 1 CHAPTER 49 Acid-Controlling Agents NDEG 26 A Pharmacology I Eliza Rivera-Mitu, RN, MSN

Mosby items and derived items © 2005, 2002 by Mosby, Inc. 88

CHAPTER 51

Antiemetic and Antinausea Agents

Page 89: Mosby items and derived items © 2005, 2002 by Mosby, Inc. 1 CHAPTER 49 Acid-Controlling Agents NDEG 26 A Pharmacology I Eliza Rivera-Mitu, RN, MSN

Mosby items and derived items © 2005, 2002 by Mosby, Inc. 89

Definitions

• Nausea– Unpleasant feeling that often precedes

vomiting

• Emesis (vomiting)– Forcible emptying of gastric, and

occasionally, intestinal contents

• Antiemetic agents– Used to relieve nausea and vomiting

Page 90: Mosby items and derived items © 2005, 2002 by Mosby, Inc. 1 CHAPTER 49 Acid-Controlling Agents NDEG 26 A Pharmacology I Eliza Rivera-Mitu, RN, MSN

Mosby items and derived items © 2005, 2002 by Mosby, Inc. 90

VC and CTZ

• Vomiting center (VC)

• Chemoreceptor trigger zone (CTZ)– Both located in the brain– Once stimulated, cause the vomiting reflex

Page 91: Mosby items and derived items © 2005, 2002 by Mosby, Inc. 1 CHAPTER 49 Acid-Controlling Agents NDEG 26 A Pharmacology I Eliza Rivera-Mitu, RN, MSN

Mosby items and derived items © 2005, 2002 by Mosby, Inc. 91

Table 51-1 Neurotransmitters involved in nausea and vomiting

Page 92: Mosby items and derived items © 2005, 2002 by Mosby, Inc. 1 CHAPTER 49 Acid-Controlling Agents NDEG 26 A Pharmacology I Eliza Rivera-Mitu, RN, MSN

Mosby items and derived items © 2005, 2002 by Mosby, Inc. 92

Mechanism of Action

• Many different mechanisms of action

• Most work by blocking one of the vomiting pathways, thus blocking the stimulus that induces vomiting

Page 93: Mosby items and derived items © 2005, 2002 by Mosby, Inc. 1 CHAPTER 49 Acid-Controlling Agents NDEG 26 A Pharmacology I Eliza Rivera-Mitu, RN, MSN

Mosby items and derived items © 2005, 2002 by Mosby, Inc. 93

Indications

• Specific indications vary per class of antiemetics

• General use: prevention and reduction of nausea and vomiting

Page 94: Mosby items and derived items © 2005, 2002 by Mosby, Inc. 1 CHAPTER 49 Acid-Controlling Agents NDEG 26 A Pharmacology I Eliza Rivera-Mitu, RN, MSN

Mosby items and derived items © 2005, 2002 by Mosby, Inc. 94

Mechanism of Action and Indications• Anticholinergic agents (ACh blockers)

– Bind to and block acetylcholine (ACh) receptors in the inner ear labyrinth

– Block transmission of nauseating stimuli to CTZ

– Also block transmission of nauseating stimuli from the reticular formation to the VC

– scopolamine– Also used as a transdermal patch for

motion sickness

Page 95: Mosby items and derived items © 2005, 2002 by Mosby, Inc. 1 CHAPTER 49 Acid-Controlling Agents NDEG 26 A Pharmacology I Eliza Rivera-Mitu, RN, MSN

Mosby items and derived items © 2005, 2002 by Mosby, Inc. 95

Mechanism of Action

Antihistamine agents (H1 receptor blockers)

– Inhibit ACh by binding to H1 receptors

– Prevent cholinergic stimulation in vestibular and reticular areas, thus preventing N&V

– dimenhydrinate, diphenhydramine, meclizine, promethazine

– Also used for nonproductive cough, allergy symptoms, sedation

Page 96: Mosby items and derived items © 2005, 2002 by Mosby, Inc. 1 CHAPTER 49 Acid-Controlling Agents NDEG 26 A Pharmacology I Eliza Rivera-Mitu, RN, MSN

Mosby items and derived items © 2005, 2002 by Mosby, Inc. 96

Mechanism of Action (cont'd)

Neuroleptic agents– Block dopamine receptors on the CTZ– Chlorpromazine, perphenazine,

triflupromazine, prochlorperazine (Compazine)

– Also used for psychotic disorders, intractable hiccups

Page 97: Mosby items and derived items © 2005, 2002 by Mosby, Inc. 1 CHAPTER 49 Acid-Controlling Agents NDEG 26 A Pharmacology I Eliza Rivera-Mitu, RN, MSN

Mosby items and derived items © 2005, 2002 by Mosby, Inc. 97

Mechanism of Action (cont'd)

Prokinetic agents– Block dopamine in the CTZ– Cause CTZ to be desensitized to impulses

it receives from the GI tract– Also stimulate peristalsis in GI tract,

enhancing emptying of stomach contents– Metoclopramide (Reglan), cisapride – Also used for GERD, delayed gastric

emptying

Page 98: Mosby items and derived items © 2005, 2002 by Mosby, Inc. 1 CHAPTER 49 Acid-Controlling Agents NDEG 26 A Pharmacology I Eliza Rivera-Mitu, RN, MSN

Mosby items and derived items © 2005, 2002 by Mosby, Inc. 98

Mechanism of Action (cont'd)

Serotonin blockers– Block serotonin receptors in the GI tract,

CTZ, and VC– dolasetron, granisetron, ondansetron

(Zofran) – Used for N&V for patients receiving

chemotherapy and postoperative nausea and vomiting

Page 99: Mosby items and derived items © 2005, 2002 by Mosby, Inc. 1 CHAPTER 49 Acid-Controlling Agents NDEG 26 A Pharmacology I Eliza Rivera-Mitu, RN, MSN

Mosby items and derived items © 2005, 2002 by Mosby, Inc. 99

Mechanism of Action (cont'd)

Tetrahydrocannabinoids– Major psychoactive substance in marijuana– Inhibitory effects on reticular formation,

thalamus, cerebral cortex– Alter mood and body’s perception of its

surroundings

Page 100: Mosby items and derived items © 2005, 2002 by Mosby, Inc. 1 CHAPTER 49 Acid-Controlling Agents NDEG 26 A Pharmacology I Eliza Rivera-Mitu, RN, MSN

Mosby items and derived items © 2005, 2002 by Mosby, Inc. 100

Mechanism of Action (cont'd)

Tetrahydrocannabinoids (cont'd)– dronabinol (Marinol)– Used for N&V associated with

chemotherapy, and anorexia associated with weight loss in AIDS patients

Page 101: Mosby items and derived items © 2005, 2002 by Mosby, Inc. 1 CHAPTER 49 Acid-Controlling Agents NDEG 26 A Pharmacology I Eliza Rivera-Mitu, RN, MSN

Mosby items and derived items © 2005, 2002 by Mosby, Inc. 101

Side Effects

• Vary according to agent used

• Zofran = headache

• Stem from their nonselective blockade of various receptors

Page 102: Mosby items and derived items © 2005, 2002 by Mosby, Inc. 1 CHAPTER 49 Acid-Controlling Agents NDEG 26 A Pharmacology I Eliza Rivera-Mitu, RN, MSN

Mosby items and derived items © 2005, 2002 by Mosby, Inc. 102

Nursing Implications• Diphenidol hydrochloride, an antinausea

agent used mainly for treatment of Meniere’s inner ear disease, should be administered with food, water, or milk to decrease GI upset and should not be used with alcohol or CNS depressants

• Scopolamine patches should be changed every 3 days

Page 103: Mosby items and derived items © 2005, 2002 by Mosby, Inc. 1 CHAPTER 49 Acid-Controlling Agents NDEG 26 A Pharmacology I Eliza Rivera-Mitu, RN, MSN

Mosby items and derived items © 2005, 2002 by Mosby, Inc. 103

Nursing Implications• Assess complete nausea and vomiting

history, including precipitating factors

• Assess current medications

• Assess for contraindications and potential drug interactions

Page 104: Mosby items and derived items © 2005, 2002 by Mosby, Inc. 1 CHAPTER 49 Acid-Controlling Agents NDEG 26 A Pharmacology I Eliza Rivera-Mitu, RN, MSN

Mosby items and derived items © 2005, 2002 by Mosby, Inc. 104

Nursing Implications

• Many of these agents cause severe drowsiness; warn patients about driving or performing any hazardous tasks

• Taking antiemetics with alcohol may cause severe CNS depression

• Teach patients to change position slowly to avoid hypotensive effects

Page 105: Mosby items and derived items © 2005, 2002 by Mosby, Inc. 1 CHAPTER 49 Acid-Controlling Agents NDEG 26 A Pharmacology I Eliza Rivera-Mitu, RN, MSN

Mosby items and derived items © 2005, 2002 by Mosby, Inc. 105

Nursing Implications

• For chemotherapy, antiemetics are often given ½ to 3 hours before a chemotherapy agent

• Monitor for therapeutic effects

• Monitor for adverse effects

Page 106: Mosby items and derived items © 2005, 2002 by Mosby, Inc. 1 CHAPTER 49 Acid-Controlling Agents NDEG 26 A Pharmacology I Eliza Rivera-Mitu, RN, MSN

Mosby items and derived items © 2005, 2002 by Mosby, Inc. 106

Nursing Implications

• Neuroleptic agents, such as Prochlorperazine (Compazine), if taken simultaneously with quinidine, may cause adverse cardiac effects

• Antihistamines, such as Meclizine, when taken with barbiturates, opioids, hypnotics, TCAs, and alcohol cause increased CNS depression